カテゴリ： MarketLine, アメリカ, 企業調査

Gilead Sciences, Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15225
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Gilead Sciences, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Gilead Sciences, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or ‘the company’) is a research based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products through distributors andf subsidiaries. It offers products under the brands: AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vitekta, Zydelig and Sovaldi. It also provides a range of pipeline products. The company has its operations in the US, Europe and other countries. The company is headquartered in Foster City, California, the US.

Scope

- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Gilead Sciences, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2015 – 2019YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Business Expansion
Gilead Sciences, Inc.: Business Reorganization
Gilead Sciences, Inc.: Contracts
Gilead Sciences, Inc.: Corporate Governance
Gilead Sciences, Inc.: Grants
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Red Flags/Distress Signals
Gilead Sciences, Inc.: Regulatory and Legal Events
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Company History
Table 4: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 5: Gilead Sciences, Inc.: Key Competitors
Table 6: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Gilead Sciences, Inc.: Targets and Partners
Table 10: Gilead Sciences, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: Gilead Sciences, Inc.: News and Events Summary
Table 22: Gilead Sciences, Inc.: Business Expansion
Table 23: Gilead Sciences, Inc.: Business Reorganization
Table 24: Gilead Sciences, Inc.: Contracts
Table 25: Gilead Sciences, Inc.: Corporate Governance
Table 26: Gilead Sciences, Inc.: Grants
Table 27: Gilead Sciences, Inc.: Market Developments
Table 28: Gilead Sciences, Inc.: Red Flags/Distress Signals
Table 29: Gilead Sciences, Inc.: Regulatory and Legal Events
Table 30: Gilead Sciences, Inc.: Research & Development
Table 31: Gilead Sciences, Inc.: Strategy and Operations

List of Figures
Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Gilead Sciences, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: Gilead Sciences, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: Gilead Sciences, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Gilead Sciences, Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Molson Coors Brewing Co (TAP)：企業の財務・戦略的SWOT分析
    Molson Coors Brewing Co (TAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • McDonald’s Australia Limited：企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Andrews Sykes Group plc (ASY)：企業の財務・戦略的SWOT分析
    Summary Andrews Sykes Group plc (ASG), formerly Braithwaite Plc, a subsidiary of EOI Sykes Sarl, is an environmental control equipment provider. The company hires, sells and installs air conditioning, pumps, chillers, heating, boilers, ventilation and dehumidification products. ASG products portfoli …
  • Assembly Biosciences Inc (ASMB)：企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • DexTech Medical AB：製薬・医療：M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Cellectis SA (ALCLS)：企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) operates as a clinical-stage biopharmaceutical company. It carries out research, develop and commercialize gene editing technology. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target a …
  • Enzo Clinical Labs Inc-医療機器分野：企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …
  • DxTerity Diagnostics Inc-医療機器分野：企業M&A・提携分析
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis and monitoring in its genomics laboratory. The company’s patient clinical research platform and dxcollect fingerstick collectio …
  • JSC Inter RAO：企業のM&A・事業提携・投資動向
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Etablissementen Franz Colruyt NV (COLR)：企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Formula Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • Cutera Inc (CUTR)：製品パイプライン分析
    Summary Cutera Inc (Cutera) is a medical device company that designs, manufactures and markets aesthetic devices. The company provides products that include enlighten, excel V, excel HR, truSculpt, and xeo. Its products are used in treatment of face and body medical aesthetics. Cutera’s enlighten de …
  • Golden Concord Holdings Ltd：電力：M&Aディール及び事業提携情報
    Summary Golden Concord Holdings Ltd (GCHL) is a diversified company. The company operates through its business divisions such as power, photovoltaic, oil and gas, smart commute and finance. Its photovoltaic division carries out manufacturing of photovoltaic materials, development of photovoltaic pow …
  • Alliance Oil Co Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • National Cheng Kung University：製薬・医療：M&Aディール及び事業提携情報
    Summary National Cheng Kung University (NCKU) is a research-led comprehensive university that offers educational and research services. The university’s services include graduate, undergraduate and postgraduate courses, research programs, master's programs, degree programs, doctoral courses, doctor' …
  • Nostra Terra Oil and Gas Company Plc (NTOG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in Texas, New Mexico, Wyoming, Kansas, Colorado …
  • Abraxas Petroleum Corp (AXAS)：企業の財務・戦略的SWOT分析
    Summary Abraxas Petroleum Corp (Abraxas) operates as an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Perm …
  • G&K Services LLC：戦略・SWOT・企業財務分析
    G&K Services LLC - Strategy, SWOT and Corporate Finance Report Summary G&K Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Advanced Proteome Therapeutics Corp (APC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-s …
  • Facebook Inc (FB)：企業の財務・戦略的SWOT分析
    Facebook Inc (FB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆